Literature DB >> 26433073

MicroRNA regulation of F-box proteins and its role in cancer.

Zhao-Hui Wu1, Lawrence M Pfeffer2.   

Abstract

MicroRNAs (miRNAs) are small endogenous non-coding RNAs, which play critical roles in cancer development by suppressing gene expression at the post-transcriptional level. In general, oncogenic miRNAs are upregulated in cancer, while miRNAs that act as tumor suppressors are downregulated, leading to decreased expression of tumor suppressors and upregulated oncogene expression, respectively. F-box proteins function as the substrate-recognition components of the SKP1-CUL1-F-box (SCF)-ubiquitin ligase complex for the degradation of their protein targets by the ubiquitin-proteasome system. Therefore F-box proteins and miRNAs both negatively regulate target gene expression post-transcriptionally. Since each miRNA is capable of fine-tuning the expression of multiple target genes, multiple F-box proteins may be suppressed by the same miRNA. Meanwhile, one F-box proteins could be regulated by several miRNAs in different cancer types. In this review, we will focus on miRNA-mediated downregulation of various F-box proteins, the resulting stabilization of F-box protein substrates and the impact of these processes on human malignancies. We provide insight into how the miRNA: F-box protein axis may regulate cancer progression and metastasis. We also consider the broader role of F-box proteins in the regulation of pathways that are independent of the ubiquitin ligase complex and how that impacts on oncogenesis. The area of miRNAs and the F-box proteins that they regulate in cancer is an emerging field and will inform new strategies in cancer treatment.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Cancer; F-box protein; microRNA

Mesh:

Substances:

Year:  2015        PMID: 26433073      PMCID: PMC4761503          DOI: 10.1016/j.semcancer.2015.09.016

Source DB:  PubMed          Journal:  Semin Cancer Biol        ISSN: 1044-579X            Impact factor:   15.707


  104 in total

Review 1.  RING domain E3 ubiquitin ligases.

Authors:  Raymond J Deshaies; Claudio A P Joazeiro
Journal:  Annu Rev Biochem       Date:  2009       Impact factor: 23.643

2.  SnapShot: F box proteins I.

Authors:  Jeffrey R Skaar; Julia K Pagan; Michele Pagano
Journal:  Cell       Date:  2009-06-12       Impact factor: 41.582

3.  JHDM1B/FBXL10 is a nucleolar protein that represses transcription of ribosomal RNA genes.

Authors:  David Frescas; Daniele Guardavaccaro; Florian Bassermann; Ryo Koyama-Nasu; Michele Pagano
Journal:  Nature       Date:  2007-11-08       Impact factor: 49.962

4.  Skp2B stimulates mammary gland development by inhibiting REA, the repressor of the estrogen receptor.

Authors:  Karina Umanskaya; Susanne Radke; Harish Chander; Rosie Monardo; Xinsong Xu; Zhen-Qiang Pan; Matthew J O'Connell; Doris Germain
Journal:  Mol Cell Biol       Date:  2007-09-04       Impact factor: 4.272

5.  FBXW7/hCDC4 is a general tumor suppressor in human cancer.

Authors:  Shahab Akhoondi; Dahui Sun; Natalie von der Lehr; Sophia Apostolidou; Kathleen Klotz; Alena Maljukova; Diana Cepeda; Heidi Fiegl; Dimitra Dafou; Dimitra Dofou; Christian Marth; Elisabeth Mueller-Holzner; Martin Corcoran; Markus Dagnell; Sepideh Zabihi Nejad; Babak Noori Nayer; Mohammad Reza Zali; Johan Hansson; Susanne Egyhazi; Fredrik Petersson; Per Sangfelt; Hans Nordgren; Dan Grander; Steven I Reed; Martin Widschwendter; Olle Sangfelt; Charles Spruck
Journal:  Cancer Res       Date:  2007-10-01       Impact factor: 12.701

Review 6.  MicroRNAs: target recognition and regulatory functions.

Authors:  David P Bartel
Journal:  Cell       Date:  2009-01-23       Impact factor: 41.582

7.  Chromosomally unstable mouse tumours have genomic alterations similar to diverse human cancers.

Authors:  Richard S Maser; Bhudipa Choudhury; Peter J Campbell; Bin Feng; Kwok-Kin Wong; Alexei Protopopov; Jennifer O'Neil; Alejandro Gutierrez; Elena Ivanova; Ilana Perna; Eric Lin; Vidya Mani; Shan Jiang; Kate McNamara; Sara Zaghlul; Sarah Edkins; Claire Stevens; Cameron Brennan; Eric S Martin; Ruprecht Wiedemeyer; Omar Kabbarah; Cristina Nogueira; Gavin Histen; Jon Aster; Marc Mansour; Veronique Duke; Letizia Foroni; Adele K Fielding; Anthony H Goldstone; Jacob M Rowe; Yaoqi A Wang; A Thomas Look; Michael R Stratton; Lynda Chin; P Andrew Futreal; Ronald A DePinho
Journal:  Nature       Date:  2007-05-21       Impact factor: 49.962

8.  The H3K36 demethylase Jhdm1b/Kdm2b regulates cell proliferation and senescence through p15(Ink4b).

Authors:  Jin He; Eric M Kallin; Yu-Ichi Tsukada; Yi Zhang
Journal:  Nat Struct Mol Biol       Date:  2008-10-05       Impact factor: 15.369

9.  Conditional inactivation of Fbxw7 impairs cell-cycle exit during T cell differentiation and results in lymphomatogenesis.

Authors:  Ichiro Onoyama; Ryosuke Tsunematsu; Akinobu Matsumoto; Taichi Kimura; Ignacio Moreno de Alborán; Keiko Nakayama; Keiichi I Nakayama
Journal:  J Exp Med       Date:  2007-11-12       Impact factor: 14.307

10.  F-box protein FBXO31 mediates cyclin D1 degradation to induce G1 arrest after DNA damage.

Authors:  Manas K Santra; Narendra Wajapeyee; Michael R Green
Journal:  Nature       Date:  2009-05-03       Impact factor: 49.962

View more
  7 in total

1.  MiR-182 promotes cell proliferation by suppressing FBXW7 and FBXW11 in non-small cell lung cancer.

Authors:  Hao Chang; Yue-Hong Liu; Li-Li Wang; Ju Wang; Zhi-Hong Zhao; Jun-Feng Qu; Sheng-Fa Wang
Journal:  Am J Transl Res       Date:  2018-04-15       Impact factor: 4.060

2.  Effects of SIDT2 on the miR-25/NOX4/HuR axis and SIRT3 mRNA stability lead to ROS-mediated TNF-α expression in hydroquinone-treated leukemia cells.

Authors:  Liang-Jun Wang; Yuan-Chin Lee; Jing-Ting Chiou; Ying-Jung Chen; Long-Sen Chang
Journal:  Cell Biol Toxicol       Date:  2022-03-18       Impact factor: 6.691

Review 3.  FOXO1: Another avenue for treating digestive malignancy?

Authors:  Feiyu Shi; Tian Li; Zhi Liu; Kai Qu; Chengxin Shi; Yaguang Li; Qian Qin; Liang Cheng; Xin Jin; Tianyu Yu; Wencheng Di; Jianwen Que; Hongping Xia; Junjun She
Journal:  Semin Cancer Biol       Date:  2017-09-28       Impact factor: 15.707

4.  Co-delivery of microRNA-21 antisense oligonucleotides and gemcitabine using nanomedicine for pancreatic cancer therapy.

Authors:  Yaqing Li; Yinting Chen; Jiajia Li; Zuoquan Zhang; Chumei Huang; Guoda Lian; Kege Yang; Shaojie Chen; Ying Lin; Lingyun Wang; Kaihong Huang; Linjuan Zeng
Journal:  Cancer Sci       Date:  2017-06-13       Impact factor: 6.716

5.  Robust Prediction of Prognosis and Immunotherapeutic Response for Clear Cell Renal Cell Carcinoma Through Deep Learning Algorithm.

Authors:  Siteng Chen; Encheng Zhang; Liren Jiang; Tao Wang; Tuanjie Guo; Feng Gao; Ning Zhang; Xiang Wang; Junhua Zheng
Journal:  Front Immunol       Date:  2022-02-07       Impact factor: 7.561

6.  Comprehensive Analysis of lncRNA and miRNA Regulatory Network Reveals Potential Prognostic Non-coding RNA Involved in Breast Cancer Progression.

Authors:  Sheng Gao; Xun Lu; Jingjing Ma; Qian Zhou; RanRan Tang; Ziyi Fu; Fengliang Wang; Mingming Lv; Cheng Lu
Journal:  Front Genet       Date:  2021-06-18       Impact factor: 4.599

Review 7.  Crosstalk Between Mammalian Autophagy and the Ubiquitin-Proteasome System.

Authors:  Nur Mehpare Kocaturk; Devrim Gozuacik
Journal:  Front Cell Dev Biol       Date:  2018-10-02
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.